NASDAQ: SYRE
Examining SYRE’s book value per share for the latest quarter
Kenneth Phillips
Currently, Spyre Therapeutics Inc’s (SYRE) stock is trading at $22.71, marking a fall of -7.15% from last night’s close. At ...
Should investors be concerned about SYRE’s high price-to-sales ratio?
Arcelia Reed
Spyre Therapeutics Inc (SYRE)’s stock is trading at $15.28 at the moment marking a rise of 1.53% from the last ...
